Clinical Trials
14 trialsNCT04403022 2026-06-03
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
Intuitive Surgical
Phase NA Active not recruiting
NCT05546476 2026-06-03
PROACC-1
Pfizer
Phase 2 Completed
NCT03693170 2026-05-29
ANCHOR-CRC
Pierre Fabre Medicament
Phase 2 Completed
NCT05185947 2026-05-29
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00159484 2026-05-28
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
University of Southern California
Phase 1/2 Completed
NCT02134925 2026-05-28
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT02965703 2026-05-28
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05064059 2026-05-26
MK-4280A-007
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03095781 2026-05-22
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Emory University
Phase 1 Completed
NCT05571293 2026-05-22
NEST-1
Weill Medical College of Cornell University
Phase 2 Active not recruiting
NCT06540807 2026-05-20
SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study
SafeHeal Inc
Phase NA Completed
NCT01150045 2026-05-19
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT04406714 2026-05-15
SCORE
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT05056896 2026-05-15
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Massachusetts General Hospital
Phase EARLY_PHASE1 Active not recruiting